Reimbursement and pricing of regenerative medicine in South Korea: key factors for achieving reimbursement.

Abstract:

:In the South Korean health technology assessment system, prices of alternative medicines, incremental cost-effectiveness ratios in pharmaco-economic evaluations and patient access improvement systems such as risk-sharing agreements are the most important factors concerning the reimbursement of regenerative medicine (RM). Research and development companies in RM should review the key features of these medicines throughout the product development cycle to increase the probability of successful reimbursement. In addition, the South Korean government should take steps to improve the system to reflect the unique characteristics and value of RM in the reimbursement and pricing policy, to revitalize research and development, and increase patient access.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Cho E,Yoo SL,Kang Y,Lee JH

doi

10.2217/rme-2020-0035

subject

Has Abstract

pub_date

2020-04-01 00:00:00

pages

1550-1560

issue

4

eissn

1746-0751

issn

1746-076X

journal_volume

15

pub_type

杂志文章
  • Interview: stemming vision loss with stem cells: seeing is believing.

    abstract::Professor Coffey joined the faculty at the University of Oxford in 1987 on completing his doctoral work. In 1989, he was awarded a personal Royal Society Research Fellowship, at the same time moving to the University of Sheffield to establish a new laboratory for retinal transplantation. After 14 years at the Universi...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.33

    authors: Coffey P

    更新日期:2009-07-01 00:00:00

  • Reliable assessment of bone marrow and bone marrow concentrates using automated hematology analyzer.

    abstract::Aim: A limiting factor in advancement of bone marrow based cell therapies is the lack of characterization of cell products delivered to patients. Methods: Using an automated hematology analyzer that can be implemented in clinical setting, the composition of bone marrow aspirates (n = 17 patients) and bone marrow conce...

    journal_title:Regenerative medicine

    pub_type: 临床试验,杂志文章

    doi:10.2217/rme-2018-0173

    authors: Mantripragada VP,Piuzzi NS,George J,Bova W,Ng M,Boehm C,Muschler GF

    更新日期:2019-07-01 00:00:00

  • Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

    abstract:AIMS:Therapeutic replacement of organs with healthy cells requires disease-specific strategies. As copper toxicosis due to ATP7B deficiency in Wilson disease produces significant liver injury, disease-specific study of transplanted cell proliferation will offer insights into cell and gene therapy mechanisms. MATERIALS...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.2.165

    authors: Malhi H,Joseph B,Schilsky ML,Gupta S

    更新日期:2008-03-01 00:00:00

  • Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

    abstract:AIM:To evaluate the in vitro immunogenic and immunomodulatory properties of induced pluripotent stem cells (iPSCs) compared with bone marrow-derived mesenchymal stromal cells (MSCs). MATERIALS & METHODS:Mouse embryonic fibroblasts (MEFs) were isolated from C3HeB/FeJ and C57BL/6J mice, and reprogrammed to generate iPSC...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.29

    authors: Schnabel LV,Abratte CM,Schimenti JC,Felippe MJ,Cassano JM,Southard TL,Cross JA,Fortier LA

    更新日期:2014-01-01 00:00:00

  • Muscle-derived stem cells in peripheral nerve regeneration: reality or illusion?

    abstract::Owing to the complicated and time-consuming regenerative process, the repair of injured peripheral nerves depends largely on ongoing stem-cell therapy. Decades ago, researchers successfully isolated and identified muscle-derived stem cells (MDSCs) and discovered their potential for multidifferentiation. MDSCs play an ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0165

    authors: Zhou J,Cui H,Lu H,Xu Z,Feng W,Chen L,Jin X,Yang X,Qi Z

    更新日期:2017-04-01 00:00:00

  • Pluripotent stem cell-derived pancreatic β-cells: potential for regenerative medicine in diabetes.

    abstract::Diabetes mellitus, which affects 346 million people, is one of the leading causes of death worldwide. Pancreatic β-cells, existing in the islets of Langerhans, play central roles in the progression of diabetes. An efficient strategy to produce functional pancreatic β-cells is important for both transplantation therapy...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.27

    authors: Kao DI,Chen S

    更新日期:2012-07-01 00:00:00

  • Cardiac repair and restoration using human embryonic stem cells.

    abstract::Advances in directed differentiation of human embryonic stem cells (hESCs) toward cardiac lineages have generated much interest within the myocardial therapy field. Beyond the promise that hESCs would provide a supply of new cardiomyocytes to the damaged heart, recent studies have also shown that paracrine effects of ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.46

    authors: Bernstein HS

    更新日期:2012-09-01 00:00:00

  • Conference scene. A bright future for tissue engineering and regenerative medicine in the Asia Pacific region.

    abstract::The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focu...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.11.7

    authors: Frith JE,Hudson JE,Cooper-White JJ

    更新日期:2011-03-01 00:00:00

  • CCRM: cultivating a culture of cooperation to advance the global regenerative medicine industry.

    abstract::Launched in June 2011, CCRM is a unique, Canadian, not-for-profit group that is solely focused on developing and commercializing regenerative medicine, cell and gene therapy technologies. Its mission is to generate sustainable health and economic benefits through global collaborations, and its vision is to be the pref...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0129

    authors: Evans A,Johnson S

    更新日期:2016-12-01 00:00:00

  • Modeling biological and economic uncertainty on cell therapy manufacturing: the choice of culture media supplementation.

    abstract:AIM:To evaluate the cost-effectiveness of autologous cell therapy manufacturing in xeno-free conditions. MATERIALS & METHODS:Published data on the isolation and expansion of mesenchymal stem/stromal cells introduced donor, multipassage and culture media variability on cell yields and process times on adherent culture ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0034

    authors: Bandeiras C,Cabral JM,Finkelstein SN,Ferreira FC

    更新日期:2018-12-01 00:00:00

  • Culture conditions for primary human limbal epithelial cells.

    abstract::The cornea at the front of the eye is covered by an epithelium. This epithelium is maintained by stem cells located at the periphery of the cornea, in a region known as the limbus. Because this region harbors the stem cells for the corneal epithelium, the so-called limbal stem cells, its culture provides considerable ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.7

    authors: Osei-Bempong C,Henein C,Ahmad S

    更新日期:2009-05-01 00:00:00

  • Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.

    abstract::Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells avoid the ethical concerns raised by the sourcing of human embryonic stem cells (hESCs) from emb...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.55

    authors: Carpenter MK,Couture LA

    更新日期:2010-07-01 00:00:00

  • Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.

    abstract:AIMS:An extensive colonization of surgical meshes with autologous fibroblasts may reduce complications. Therefore, we aimed to establish a technique that allows isolation and propagation of fibroblasts from vaginal biopsies. Using these cells we tested the applicability of several clinically applied meshes for fibrobla...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.4.2.197

    authors: Skala CE,Petry IB,Gebhard S,Hengstler JG,Albrich SB,Maltaris T,Naumann G,Koelbl H

    更新日期:2009-03-01 00:00:00

  • Leukocyte-rich platelet-rich plasma application in post-traumatic osteoarthritis with popliteal cyst: a case report.

    abstract::Aim: To describe the successful treatment of a Baker's cyst in the setting of post-traumatic osteoarthritis using ultrasound-guided injection of platelet-rich plasma. Setting: Outpatient sports clinic. Patient: 29-year old male basketball player. Case description: The patient presented with 2-months history of right k...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2020-0021

    authors: Song B,Yeh PC,Jayaram P

    更新日期:2020-06-01 00:00:00

  • The past, present and future of ligament regenerative engineering.

    abstract::Regenerative engineering has been defined as the convergence of Advanced Materials Sciences, Stem Cell Sciences, Physics, Developmental Biology and Clinical Translation for the regeneration of complex tissues and organ systems. Anterior cruciate ligament (ACL) reconstruction necessitates the regeneration of bone, liga...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0125

    authors: Mengsteab PY,Nair LS,Laurencin CT

    更新日期:2016-12-01 00:00:00

  • The use of hematopoietic stem cells in autoimmune diseases.

    abstract::Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cycloph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2015-0057

    authors: Ben Nasr M,Bassi R,Usuelli V,Valderrama-Vasquez A,Tezza S,D'Addio F,Fiorina P

    更新日期:2016-06-01 00:00:00

  • The long and winding road that leads to a cure for epidermolysis bullosa.

    abstract::Inherited epidermolysis bullosa (EB) is a family of rare genetic skin disorders characterized by structural and mechanical fragility of skin and mucosal membranes. The main feature of EB is the presence of recurrent skin blistering or erosions, which have a profound impact in the quality of life of EB patients and, in...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.33

    authors: Carulli S,Contin R,De Rosa L,Pellegrini G,De Luca M

    更新日期:2013-07-01 00:00:00

  • Short-term outcomes after pure bone marrow aspirate injection for severe knee osteoarthritis: a case series.

    abstract::Background: Bone marrow aspiration (BMA) is among a group of autologous cell-based therapies currently being explored to treat osteoarthritis (OA). Materials & methods: This retrospective case study observed ten patients (13 knees) with severe knee OA who failed extensive conservative treatment and were treated with B...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0113

    authors: Colberg RE,Jurado Vélez JA,Walsh KP,Fleisig G

    更新日期:2020-07-01 00:00:00

  • Functional motor recovery after peripheral nerve repair with an aligned nanofiber tubular conduit in a rat model.

    abstract:AIM:Current synthetic tubular conduits are inferior to nerve autograft for the repair of segmental peripheral nerve injuries. We examined motor outcomes with the use of longitudinally aligned poly (L-lactide-co-caprolactone) nanofiber conduits for repair of nerve gap injury in a rat model. METHODS:Ten-millimeter segme...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.87

    authors: Jin J,Park M,Rengarajan A,Zhang Q,Limburg S,Joshi SK,Patel S,Kim HT,Kuo AC

    更新日期:2012-11-01 00:00:00

  • Cell-based therapy approaches: the hope for incurable diseases.

    abstract::Cell therapies aim to repair the mechanisms underlying disease initiation and progression, achieved through trophic effect or by cell replacement. Multiple cell types can be utilized in such therapies, including stem, progenitor or primary cells. This review covers the current state of cell therapies designed for the ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.14.35

    authors: Buzhor E,Leshansky L,Blumenthal J,Barash H,Warshawsky D,Mazor Y,Shtrichman R

    更新日期:2014-01-01 00:00:00

  • Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.

    abstract::Human embryonic stem cells (ESCs) can be induced to differentiate into a wide range of tissues that soon could be used for therapeutic applications in regenerative medicine. Despite their developmental potential, sources used to generate human ESC lines raise serious ethical concerns, which recently prompted efforts t...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.09.46

    authors: Lee H,Park J,Forget BG,Gaines P

    更新日期:2009-09-01 00:00:00

  • Identity and ownership issues in the regulation of autologous cells.

    abstract::Clinical application of autologous cells by businesses promoting unproven stem cell treatments represents the largest growth sector in this problematic industry, but also presents special challenges to regulators. Patients frequently identify autologous cells as personal property, using the language of 'ownership'. Th...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0063

    authors: Sipp D

    更新日期:2017-10-01 00:00:00

  • The UK Stem Cell Bank: a UK government-funded, international resource center for stem cell research.

    abstract::The UK Stem Cell Bank is a UK Research Council-funded initiative that aims to provide ethically sourced and quality controlled stocks of cells for researchers and also establish seed stocks of cell lines for clinical trials. Whilst the Bank is prohibited from carrying out basic stem cell research (to avoid conflicts o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.1.1.139

    authors: Stacey G,Hunt CJ

    更新日期:2006-01-01 00:00:00

  • Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

    abstract::Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicate...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.5.771

    authors: Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

    更新日期:2007-09-01 00:00:00

  • Interview: Discussions on the development of human embryonic stem cell-based therapies.

    abstract::Dr Jane Lebkowski joined Geron Corporation in 1998 and is currently Senior Vice President and Chief Scientific Officer of the Regenerative Medicine Division. Dr Lebkowski heads Geron's human embryonic stem cell program, and is responsible for all research, preclinical development, product development, manufacturing an...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme.09.49

    authors: Lebkowski JS

    更新日期:2009-09-01 00:00:00

  • In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

    abstract::Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro. Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potenti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0067

    authors: Nieto-Nicolau N,Martín-Antonio B,Müller-Sánchez C,Casaroli-Marano RP

    更新日期:2020-03-01 00:00:00

  • Biomaterials combined with cell therapy for treatment of spinal cord injury.

    abstract::Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.121

    authors: Kubinová S,Syková E

    更新日期:2012-03-01 00:00:00

  • Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance.

    abstract::The thymus is required for generation of a self-tolerant, self-restricted T-cell repertoire. The capacity to manipulate or replace thymus function therapeutically would be beneficial in a variety of clinical settings, including for improving recovery following bone marrow transplantation, restoring immune system funct...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.15.8

    authors: Bredenkamp N,Jin X,Liu D,O'Neill KE,Manley NR,Blackburn CC

    更新日期:2015-01-01 00:00:00

  • Manufacturing MSCs for commercial application: an interview with Ross Macdonald.

    abstract::Ross Macdonald is the CEO and Managing Director of Cynata Therapeutics Limited (Australia). He has over 30 years of experience and a track record of success in pharmaceuticals and biotechnology businesses. His career history includes positions as Vice President of Business Development for Sinclair Pharmaceuticals Ltd ...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme-2019-0122

    authors: Macdonald R

    更新日期:2019-11-01 00:00:00

  • Company profile: Sistemic Ltd.

    abstract::Founded in 2009 and headquartered in Glasgow, Scotland, UK, Sistemic Ltd has developed from a thought in the minds of four scientists into a company working globally to play its part in delivering the exciting opportunities for improvements in human health presented by cell therapies and regenerative medicine products...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.13.58

    authors: Reid J

    更新日期:2013-09-01 00:00:00